Global Dialysis - FDA panel to review anemia drug peginesatide (from Affymax) on Dec. 7, 2011.

FDA panel to review anemia drug peginesatide (from Affymax) on Dec. 7, 2011.

Businessweek: The FDA will ask its panel of hematology experts to review the safety and effectiveness of the drug peginesatide at a Dec. 7 meeting. The FDA is not required to follow the group's advice, though it often does.

...